Holen Sie sich die Stockscreener-App
20.91
0.38%
-0.08
Handel nachbörslich:
20.91
Schlusskurs vom Vortag:
$20.99
Offen:
$20.9
24-Stunden-Volumen:
175.39K
Relative Volume:
0.97
Marktkapitalisierung:
$922.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+23.14%
1M Leistung:
+2.35%
6M Leistung:
+3.11%
1J Leistung:
+0.00%
1-Tages-Spanne:
$20.50
$21.29
1-Wochen-Bereich:
$16.87
$21.70
52-Wochen-Spanne:
$7.255
$24.90
Sionna Therapeutics Inc Stock (SION) Company Profile
Firmenname
Sionna Therapeutics Inc
Sektor
Branche
Telefon
617-819-2020
Adresse
21 HICKORY DRIVE, SUITE 500, WALTHAM
Vergleichen Sie SION mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
20.91 | 925.49M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Eingeleitet | Guggenheim | Buy |
| 2025-03-04 | Eingeleitet | Stifel | Buy |
| 2025-03-04 | Eingeleitet | TD Cowen | Buy |
Sionna Therapeutics Inc Aktie (SION) Neueste Nachrichten
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser
Why Sionna Therapeutics Inc. is moving todayShort Squeeze Opportunities with Indicators - Newser
Has Sionna Therapeutics Inc. found a price floorProfit Target Planning with Exit Confidence - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockValue Investing Checklist with Entry Signals - Newser
Can Sionna Therapeutics Inc. recover in the next quarterFree Watchlist for Smart Swing Trading - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionShort-Term Market Movement Forecast Report - Newser
Sionna Therapeutics (NASDAQ:SION) Shares Gap Up After Better-Than-Expected Earnings - Defense World
Custom strategy builders for tracking Sionna Therapeutics Inc.Free Daily Picks With Predictable Performance - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveFree Stock Screener With Smart Filters - Newser
What makes Sionna Therapeutics Inc. stock price move sharplyReversal Pattern Insights with Entry Tips - Newser
Sionna Therapeutics shares rise 12.99% intraday after reporting positive Phase 1 data for SION-719 and SION-451. - AInvest
Guggenheim reiterates Buy rating on Sionna Therapeutics stock at $45 target - Investing.com Canada
Sionna Therapeutics' Q2 Net Loss Narrows - MarketScreener
Earnings Flash (SION) Sionna Therapeutics Posts Q2 Net Loss $0.41 a Share, vs. FactSet Est of $0.65 Loss - MarketScreener
Sionna Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewswire
Breakthrough in Cystic Fibrosis Treatment: Sionna's Novel Drugs Clear Phase 1, Phase 2 Trials Coming - Stock Titan
Custom strategy builders for tracking Cadrenal Therapeutics Inc.Long Term Stock Planner with Safety Checks - Newser
Using RSI to spot recovery in Sionna Therapeutics Inc.Buy and Exit Strategy Based on Momentum - Newser
Top chart patterns to watch in Sionna Therapeutics Inc.Weekly Breakout Forecast with Entry Zones - Newser
sionna therapeutics, inc. Earnings dates - RTTNews
Is Sionna Therapeutics Inc. trending in predictive chart modelsFree Trade Ready Stock Watch for Short Term - Newser
Guggenheim Initiates Sionna Therapeutics(SION.US) With Buy Rating, Announces Target Price $45 - 富途牛牛
Sentiment analysis tools applied to Sionna Therapeutics Inc.Buy Zone Strategy with Pattern Recognition - Newser
Published on: 2025-08-09 05:35:12 - Newser
Is AMRN stock reversal real or fakeLong Term Stock Growth Plan Suggestions - Newser
Certain Options of Sionna Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-AUG-2025. - MarketScreener
What momentum shifts mean for Sionna Therapeutics Inc.Entry Zone Watchlist With Momentum Focus - Newser
What is the dividend policy of Sionna Therapeutics Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
Should I hold or sell Sionna Therapeutics Inc. stock in 2025Build wealth steadily with proven investment strategies - Jammu Links News
Is Sionna Therapeutics Inc. a growth stock or a value stockStay informed with expert market forecasts - Jammu Links News
Is Sionna Therapeutics Inc. stock overvalued or undervaluedUnlock daily stock market insights for success - Jammu Links News
Finanzdaten der Sionna Therapeutics Inc-Aktie (SION)
Es liegen keine Finanzdaten für Sionna Therapeutics Inc (SION) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):